Expanded newborn screening and confirmatory follow-up testing for inborn errors of metabolism detected by tandem mass spectrometry

@inproceedings{Ozben2013ExpandedNS,
  title={Expanded newborn screening and confirmatory follow-up testing for inborn errors of metabolism detected by tandem mass spectrometry},
  author={Tomris Ozben},
  booktitle={Clinical chemistry and laboratory medicine},
  year={2013}
}
  • T. Ozben
  • Published in
    Clinical chemistry and…
    2013
  • Medicine
Abstract Newborn screening (NBS) of inborn errors of metabolism (IEM) is a coordinated comprehensive system consisting of education, screening, follow-up of abnormal test results, confirmatory testing, diagnosis, treatment, and evaluation of periodic outcome and efficiency. The ultimate goal of NBS and follow-up programs is to reduce morbidity and mortality from the disorders. Over the past decade, tandem mass spectrometry (MS/MS) has become a key technology in the field of NBS. It has replaced… 
An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand
TLDR
At the current ceiling threshold, neonatal screening using MS/MS in the Thai context is not cost-effective, however, the treatment of patients who were detected early for PKU, IVA, MSUD, and MCD are considered favourable.
Screening newborns for metabolic disorders based on targeted metabolomics using tandem mass spectrometry
  • H. Yoon
  • Medicine
    Annals of pediatric endocrinology & metabolism
  • 2015
TLDR
Tandem mass spectrometry is a powerful tool to improve screening of newborns for diverse metabolic diseases and is likely to be used to analyze other treatable disorders or significantly improve existing newborn tests to allow broad scale and precise testing.
Improving the Speed and Selectivity of Newborn Screening Using Ion Mobility Spectrometry-Mass Spectrometry.
TLDR
The utility of ion mobility spectrometry (IMS) to enhance the accuracy of MS assays for primary (tier 1) screening is explored and the results suggest that ∼400 IMS resolving power would be required to confidently assess most NBS biomarkers of interest in dried blood spots (DBSs) that currently require follow-up testing.
NMR-based newborn urine screening for optimized detection of inherited errors of metabolism
TLDR
A non-invasive and readily accessible urine sample contains enough information to assess the potential existence of a substantial number of IEMs in newborns, using a single, automated and standardized 1H- NMR-based analysis.
Institutional experience of newborn screening for inborn metabolism disorders by tandem MS in the Turkish population
TLDR
Because of the high rate of consanguineous marriages in Turkey, the development of a nationwide screening panel is necessary for early detection and management of potentially treatable inherited metabolic disorders.
Incorporation of second-tier tests and secondary biomarkers to improve positive predictive value (PPV) rate in newborn metabolic screening program.
TLDR
This study showed a high incidence of metabolic disease due to a high rate of consanguineous marriages in Iran and indicated that incorporation of second-tier tests and secondary biomarkers improves PPV of neonatal screening programs.
Analytical Evaluation of the Ideal Strategy for High-Throughput Flow Injection Analysis by Tandem Mass Spectrometry in Routine Newborn Screening
TLDR
Evaluated analytical performances of the RenataDX Screening System, a fully integrated flow-injection MS/MS (FIA-MS/MS) IVD system for high-throughput dried blood spot analysis in a routine NBS laboratory, suggest that both methods correlate well with clinically insignificant differences that do not impact the NBS result.
A comprehensive multiplex PCR based exome-sequencing assay for rapid bloodspot confirmation of inborn errors of metabolism
TLDR
The PEARS assay has clinical utility as a rapid and cost effective second-tier test to assist the clinician to accurately diagnose newborns with a suspected IEM.
Misclassification of VLCAD carriers due to variable confirmatory testing after a positive NBS result
TLDR
Compared to the historic multi-algorithmic confirmatory testing protocol, the findings suggest that many out-of-range VLCAD cases that do not receive molecular confirmatoryTesting could be carriers mistakenly classified as false positives.
...
1
2
3
4
...

References

SHOWING 1-10 OF 99 REFERENCES
Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns.
TLDR
Multianalyte technologies such as MS/MS are suitable for newborn screening and other mass screening programs because they improve the detection of many diseases in the current screening panel while enabling expansion to disorders that are now recognized as important and need to be identified in pediatric medicine.
Newborn Screening by Tandem Mass Spectrometry
TLDR
The expansion of newborn screening programs by inclusion of an additional 15 to 30 metabolic disorders has the potential to decrease significantly the morbidity and mortality associated with inborn errors of metabolism and could offer the clinician critical diagnostic information when caring for an acutely ill neonate.
Making the case for objective performance metrics in newborn screening by tandem mass spectrometry.
TLDR
The repeat rate and the proportion of cases with abnormal findings actually been reported are new metrics proposed here as an objective mean to express the overall noise in a program, where noise is defined as the total number of abnormal results obtained using a given set of cut-off values.
Use of Tandem Mass Spectrometry for Newborn Screening of 6 Lysosomal Storage Disorders in a Korean Population
TLDR
The enzyme activities measured in the DBSs were consistently lower in patients with LSDs than in normal newborns, and the performance of the revised techniques for MS/MS detection and enzyme assays was of the generally acceptable standard.
Newborn screening for lysosomal storage diseases: an ethical and policy analysis
  • L. Ross
  • Medicine
    Journal of Inherited Metabolic Disease
  • 2011
TLDR
This manuscript evaluates three lysosomal storage diseases included in this multiplex screening test—Pompe disease, Fabry disease, and Krabbe disease and shows that they fail to meet some of the critical Wilson and Jungner criteria and thus are not ready for inclusion in universal NBS panels.
State Newborn Screening in the Tandem Mass Spectrometry Era: More Tests, More False-Positive Results
TLDR
The number of infants who may receive false-positive results and be labeled falsely as having disease is potentially sizeable, and a more cautious approach is needed.
Newborn screening.
TLDR
The aim of newborn screening is to detect newborns with serious, treatable disorders so as to facilitate appropriate interventions to avoid or ameliorate adverse outcomes, and modification of tandem mass spectrometry and DNA extraction and analysis from newborn screening dried blood spot and Susceptibility testing are considered.
...
1
2
3
4
5
...